Menu

Eyes-On Glasses System – vein detection eyewear

By Maja Bosanac

10 Comments1 December 2013

Evena Medical, a company developing innovative imaging technologies, has introduced Eyes-On Glasses System – a novel vascular imaging system which provides augmented reality information on a set of smart glasses. This vein detection device uses multi-spectral 3D imaging and wireless connectivity to detect patients’ veins through the skin. With Eyes-On Glasses System, even hard-to-locate veins are easy to see and access.

“Studies have shown that up to 40 percent of IV starts require multiple attempts to locate and access a vein, which not only wastes valuable nursing time but also delays therapy and causes patient discomfort and dissatisfaction”, said Frank Ball, Evena Medical President and CEO.

The Eyes-On technology provides clear, anatomically accurate and real time images. Evena Medical has designed every aspect of the system to make it lightweight, comfortable, and wearable over existing eyewear. Since the glasses unit is battery powered, the device is portable and easy to wear – making the intravenous access fast, accurate and precise.

They utilize the Epson Moverio smart glasses technology platform and its unique “look-through” capabilities. This technology has a binocular design that relies on augmented reality. It projects overlays of digital content onto the real-world in the center of the wearer’s field of view.

Multi-spectral 3D imaging enables users of the Eyes-On Glasses to see fine detail both on and deep beneath the skin using two digital hypersensitive cameras. The cameras can be used to transmit real time images to remote locations via Bluetooth, WiFi and 3G wireless connectivity.

Evena Medical Eyes-On technology also includes internal digital storage that enables easy verification and documentation of vein condition throughout the patient’s care. The system also interfaces with hospital electronic medical records systems for seamless documentation.

With these glasses nurses can quickly and easily access patients’ veins for IV treatments. That makes them ideal for use in centers for emergency care, physician offices, clinics or hospitals. They are expected to be commercially available in the first quarter of the next year.